细管胸腔闭式引流治疗恶性胸水临床观察(附14例分析)  

Clinical observation of malignant pleural effusion treating with small catheter for closing drainage in fourteen patients

作　　者：胡长路[1] 张万亨[1] 庄建生[1] 林新民[1] 胡冰[1] 季楚舒[1] 

机构地区：[1]安徽省立医院肿瘤科,合肥230001

出　　处：《临床肿瘤学杂志》2001年第2期131-132,共2页Chinese Clinical Oncology

摘　　要：目的:探讨细管胸腔闭式引流术与VP16、红霉素治疗恶性胸腔积液的临床疗效。方法:对有临床、病理依据的恶性胸腔积液患者,经X片、B超胸水定位后置16＃锁骨下静脉穿刺留置针入胸腔,积液引流干净后予胸腔内注射胸膜硬化剂VP16、红霉素。结果:14例恶性胸腔积液患者显效6例、有效5例、无效3例。无效者均为肺癌复治患者。结论:该法治疗恶性胸腔积液具有患者痛苦少、疗效确切及不易复发等优点,便于临床应用。Objective: To evaluate the clinical effects of malignant pleural effusions in treatment using small catheter for closing drainage and VP16 and erythromycin for intrapleural injection. Methods: The patients were all malignant pleural fluid proved patho-logicall. The intrapleural installation of 16 small catheter was used for fluid drainage, after location of fluid level by X-ray films and ultrasound scan. The sclerosing agents were Vpl6 and erythromacin injected intrapleurally after the pleural fluids were adequate evacuated. Results; The 14 patients were evaluable for response. The complete, partial, no response were in 6, 5, 3 cases respectively. The non-responders were all retreated malignant effusions.Conclusions: This approach has a series of advantages, such as less painful, fayorable effects, lessed retreated necessarily and useful clinically.

关 键 词：恶性胸腔积液 细管闭式引注术 红霉素/VP16 胸膜硬化术 

分 类 号：R730.53[医药卫生—肿瘤] R561.3[医药卫生—临床医学]